Diagnostic Medical Systems S.A.

DB:DMS1 Stock Report

Market Cap: €14.0m

Diagnostic Medical Systems Past Earnings Performance

Past criteria checks 0/6

Diagnostic Medical Systems's earnings have been declining at an average annual rate of -20.7%, while the Medical Equipment industry saw earnings declining at 2.5% annually. Revenues have been growing at an average rate of 6.4% per year.

Key information

-20.7%

Earnings growth rate

-17.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate6.4%
Return on equity-122.1%
Net Margin-32.2%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Diagnostic Medical Systems makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:DMS1 Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2447-15160
31 Mar 2445-12150
31 Dec 2344-10140
30 Jun 23402120
31 Mar 2338-1120
31 Dec 2237-5120
30 Jun 2238-4120
31 Mar 2238-3120
31 Dec 2138-2120
30 Jun 2137-3130
31 Mar 2136-3130
31 Dec 2035-4130
30 Sep 2036-7140
30 Jun 2036-3140
31 Mar 2035-3140
31 Dec 1934-3140
30 Sep 1932-4130
30 Jun 1931-5130
31 Mar 1929-5130
31 Dec 1828-5130
30 Sep 1828-5130
30 Jun 1829-5130
31 Mar 1830-4130
31 Dec 1730-3130
30 Sep 1734-2150
30 Jun 17370160
31 Mar 1739-1180
31 Dec 1641-1190
30 Sep 1642-1180
30 Jun 1642-1180
31 Mar 1640-1170
31 Dec 1539-1160
30 Sep 1535-1150
30 Jun 1532-1130
31 Mar 1529-1120
31 Dec 1426-1100
30 Sep 1425-190
30 Jun 1424-190
31 Mar 1423-190

Quality Earnings: DMS1 is currently unprofitable.

Growing Profit Margin: DMS1 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: DMS1 is unprofitable, and losses have increased over the past 5 years at a rate of 20.7% per year.

Accelerating Growth: Unable to compare DMS1's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: DMS1 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: DMS1 has a negative Return on Equity (-122.14%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 11:56
End of Day Share Price 2025/01/08 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Diagnostic Medical Systems S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution